Regression and differentiation of neuroblastoma tumors in mice treated with differentiating agents-prostaglandin E1 and a phosphodiesterase inhibitor, RO 20-1724
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 16 (3) , 287-295
- https://doi.org/10.1016/0304-3835(82)90009-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A Study of the Effect of Papaverine in Neuroblastoma Using the Experimental C1300 Murine SystemOncology, 1978
- Cyclic AMP in neuroblastoma, ganglioneuroma and sympathetic gangliaCellular and Molecular Life Sciences, 1977
- Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reactionNature, 1976
- Management of Disseminated NeuroblastomaCA: A Cancer Journal for Clinicians, 1975
- DIFFERENTIATION OF NEUROBLASTOMA CELLS IN CULTUREBiological Reviews, 1975
- An experimental model for the therapy of mouse neuroblastomaJournal of Pediatric Surgery, 1973
- Basal Level of Neurotransmitter Synthesizing Enzymes and Effect of Cyclic AMP Agents on the Morphological Differentiation of Isolated Neuroblastoma ClonesNature New Biology, 1973
- Cooperation of Immune Lymphoid Cells with Macrophages in Tumour ImmunityNature, 1970
- Studies on cellular immunity to human neuroblastoma cellsInternational Journal of Cancer, 1970
- Evidence for immune reactions to neuroblastoma and future possibilities for investigationJournal of Pediatric Surgery, 1970